Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H25NO |
Molecular Weight | 295.4186 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCCCC1(OC(C)(C)C2=C1C=CC=C2)C3=CC=CC=C3
InChI
InChIKey=LJBBMCNHIUJBDU-UHFFFAOYSA-N
InChI=1S/C20H25NO/c1-19(2)17-12-7-8-13-18(17)20(22-19,14-9-15-21-3)16-10-5-4-6-11-16/h4-8,10-13,21H,9,14-15H2,1-3H3
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological studies of a new series of bicyclic thymoleptics. | 1966 |
|
Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect? | 2002 Jul |
|
Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter. | 2004 Aug |
|
PET imaging of norepinephrine transporters. | 2006 |
|
Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram. | 2006 Jan-Feb |
|
From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies. | 2008 May 22 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5768100
rodents: 12.5-50 mg/kg i.p.
Route of Administration:
Intraperitoneal
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29747
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10811MIG
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
C84195
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
7182-51-6
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
DB09190
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
DTXSID10864019
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
Talopram
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
23573
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
100000083207
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
5PY881HC79
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL299233
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
C496684
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY | |||
|
3077
Created by
admin on Sat Dec 16 05:26:14 GMT 2023 , Edited by admin on Sat Dec 16 05:26:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)